West Pharmaceutical Services, Inc. (WST) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Exton, PA, United States. The current CEO is Eric Green.
WST has IPO date of 1980-03-17, 10,600 full-time employees, listed on the NYSE, a market capitalization of $19.3B.
West Pharmaceutical Services, Inc. is a leading global manufacturer of containment and delivery systems for injectable drugs and healthcare products, serving pharmaceutical, biologic, and medical device companies across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through two main segments: Proprietary Products, which includes stoppers, seals, syringe components, self-injection devices, and its proprietary Crystal Zenith polymer platform for vials and cartridges; and Contract-Manufactured Products, which provides design and assembly services for surgical, diagnostic, ophthalmic, and drug delivery devices. Beyond manufacturing, West offers comprehensive support services including analytical testing, regulatory expertise, engineering development, and after-sales technical support to enhance product quality and safety. Founded in 1923 and headquartered in Exton, Pennsylvania, the company distributes its products through a global network of sales representatives, distributors, and contract agents.
